Issue navigation
Volume 18, Issue 5, May 2024
Editorial
Unravelling the Smoke Trail: Maternal Smoking, Childhood Exposure, and their Impact on Inflammatory Bowel Diseases
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 659–660, https://doi.org/10.1093/ecco-jcc/jjae032
Original Articles
Tobacco Smoke Exposure in Early Childhood and Later Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 661–670, https://doi.org/10.1093/ecco-jcc/jjae020
Impact of Maternal Smoking, Offspring Smoking, and Genetic Susceptibility on Crohn’s Disease and Ulcerative Colitis
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 671–678, https://doi.org/10.1093/ecco-jcc/jjad200
Higher Serum Infliximab Concentrations Following Subcutaneous Dosing are Associated with Deep Remission in Patients with Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 679–685, https://doi.org/10.1093/ecco-jcc/jjad188
Cancer Biology or Ineffective Surveillance? A Multicentre Retrospective Analysis of Colitis-Associated Post-Colonoscopy Colorectal Cancers
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 686–694, https://doi.org/10.1093/ecco-jcc/jjad189
Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 695–707, https://doi.org/10.1093/ecco-jcc/jjad190
Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn’s Disease
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 708–719, https://doi.org/10.1093/ecco-jcc/jjad199
Treatment of Antibiotic Refractory Chronic Pouchitis With JAK Inhibitors and S1P Receptor Modulators: An ECCO CONFER Multicentre Case Series
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 720–726, https://doi.org/10.1093/ecco-jcc/jjad194
Histological Image-based Ensemble Model to Identify Myenteric Plexitis and Predict Endoscopic Postoperative Recurrence in Crohn’s Disease: A Multicentre, Retrospective Study
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 727–737, https://doi.org/10.1093/ecco-jcc/jjad196
Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn’s Disease: Real-world Data from the International Prospective PIBD-SETQuality Inception Cohort Study
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 738–750, https://doi.org/10.1093/ecco-jcc/jjad197
The Role of Platelets and von Willebrand Factor in the Procoagulant Phenotype of Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 751–761, https://doi.org/10.1093/ecco-jcc/jjad198
The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 762–772, https://doi.org/10.1093/ecco-jcc/jjad192
Review Article
Anti-tumor Necrosis Factor Alpha Versus Corticosteroids: A 3-fold Difference in the Occurrence of Venous Thromboembolism in Inflammatory Bowel Disease－A Systematic Review and Meta-analysis
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 773–783, https://doi.org/10.1093/ecco-jcc/jjad193
Letter to the Editor
Kidney Injuries as Extra-intestinal Manifestation of Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 784–786, https://doi.org/10.1093/ecco-jcc/jjad191
